Cargando…
Development and validation a simple scoring system to identify malignant pericardial effusion
BACKGROUND: Malignant pericardial effusion (MPE) is a serious complication in patients with advanced malignant tumors, which indicates a poor prognosis. However, its clinical manifestations lack specificity, making it challenging to distinguish MPE from benign pericardial effusion (BPE). The aim of...
Autores principales: | Jin, Xiaxia, Hu, Lingling, Fang, Meidan, Zheng, Qiaofei, Yuan, Yuan, Lu, Guoguang, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751446/ https://www.ncbi.nlm.nih.gov/pubmed/36531065 http://dx.doi.org/10.3389/fonc.2022.1012664 |
Ejemplares similares
-
Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
por: Chiruvella, Varsha, et al.
Publicado: (2022) -
Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram
por: Wu, Aihua, et al.
Publicado: (2021) -
Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014) -
The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023) -
Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)